Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma

Figure 6 Comparison of the sensitivity and specificity for hepatocellular carcinoma survival prediction by the 5-long non-coding RNA signature and two existing signatures in the entire set. A: Kaplan-Meier analysis of patients’ overall survival in the high-risk (n = 185) and low-risk (n = 185) subgroups based on the 3GeneSig in the entire set (left panel) and comparison of the survival difference based on the 5 long non-coding RNA (lncRNA) signature and the 3GeneSig by Kaplan-Meier analysis (right panel); B: Kaplan-Meier analysis of patients’ overall survival in the high-risk (n = 186) and low-risk (n = 184) subgroups based on the ZhongSig in the entire set (left panel) and comparison of the survival difference based on the 5 lncRNA signature and the ZhongSig (right panel); C: The ROC analysis of overall survival for the 5-lncRNA signature, ZhongSig and 3GeneSig.